CAS: 865466-24-6 - Narlaprevir

Formel: C₃₆H₆₁N₅O₇S

InChl: InChI=1S/C36H61N5O7S/c1-10-11-15-24(27(42)30(44)37-22-16-17-22)38-29(43)26-25-23(35(25,8)9)20-41(26)31(45)28(33(2,3)4)39-32(46)40-36(18-13-12-14-19-36)21-49(47,48)34(5,6)7/h22-26,28H,10-21H2,1-9H3,(H,37,44)(H,38,43)(H2,39,40,46)/t23-,24-,25-,26-,28+/m0/s1

InChI Key: InChIKey=RICZEKWVNZFTNZ-LFGITCQGSA-N

SMILES: O=C(NC(C(=O)N1CC2C(C1C(=O)NC(C(=O)C(=O)NC3CC3)CCCC)C2(C)C)C(C)(C)C)NC4(CCCCC4)CS(=O)(=O)C(C)(C)C

Synonyme:

• (1R,2S,5S)-N-[(1S)-1-[(Cyclopropylamino)oxoacetyl]pentyl]-3-[(2S)-2-[[[[1-[[(1,1-dimethylethyl)sulfonyl]methyl]cyclohexyl]amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide
• 3-Azabicyclo[3.1.0]hexane-2-carboxamide, N-[(1S)-1-[(cyclopropylamino)oxoacetyl]pentyl]-3-[(2S)-2-[[[[1-[[(1,1-dimethylethyl)sulfonyl]methyl]cyclohexyl]amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-, (1R,2S,5S)-
• 3-Azabicyclo[3.1.0]hexane-2-carboxamide, N-[(1S)-1-[2-(cyclopropylamino)-2-oxoacetyl]pentyl]-3-[(2S)-2-[[[[1-[[(1,1-dimethylethyl)sulfonyl]methyl]cyclohexyl]amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-, (1R,2S,5S)-
• Sch 900518

Narlaprevir

CAS: 865466-24-6

• Formel: C₃₆H₆₁N₅O₇S
• Molekulargewicht: 707.96

Narlaprevir-d4

CAS: 865466-24-6

• Formel: C₃₆D₄H₅₇N₅O₇S
• Farbe und Form: Neat
• Molekulargewicht: 711.989

Narlaprevir

CAS: 865466-24-6

Narlaprevir is an effective, selective, and orally bioavailable NS3 protease inhibitor(Ki=6 nM; EC90=40 nM).

• Formel: C₃₆H₆₁N₅O₇S
• Reinheit: 98%
• Farbe und Form: Solid
• Molekulargewicht: 707.96

Narlaprevir

CAS: 865466-24-6

Applications Narlaprevir is an NS3/4A protease inhibitor used in the treatment of hepatitis C virus, …

• Formel: C₃₆H₆₁N₅O₇S
• Farbe und Form: White to Off-White Solid
• Molekulargewicht: 707.96

Narlaprevir

CAS: 865466-24-6

Narlaprevir is a protease inhibitor that inhibits the activity of HIV proteases, which are enzymes …

• Formel: C₃₆H₆₁N₅O₇S
• Reinheit: Min. 95%
• Molekulargewicht: 707.96 g/mol